Navigation Links
FDA Approve S Robotic Device to Help Stroke Patients

Robotic devices, that help stroke patients practise daily tasks with impaired limbs, are proliferating in US .

The US Food and Administration has approved a new robotic device called the Myomo e100, designed to help stroke patients regain motion in their arms. It is to hit the market shortly.

Worn as an arm brace, the device works by sensing weak electrical activity in patients arm muscles and providing just enough assistance that they can complete simple exercises, like lifting boxes or flipping on light switches. By practicing such tasks, patients may begin to relearn how to extend and flex the arm, rebuilding and strengthening neurological pathways in the process.

The device is designed to help get patients over a functional hump so they can start moving the weakened arm again, said John McBean, a mechanical engineer who developed the technology with Kailas Narendran, an electrical engineer and computer scientist.

(The two began the project in 2002, in a graduate robotics class at Massachusetts Institute of Technology (M.I.T).)

And the more they are able to use the arm, the more improvement they begin to see, McBean continued. So its a virtuous cycle.

This is an area thats exploding, said Hermano Igo Krebs, a principal research scientist at M.I.T. and one of the first scientists to envision robot-assisted therapy for stroke patients and others with brain injuries and neurological disorders.

There are now a hundred groups around the world working on this. In 5 to 10 years, I expect well see these kinds of devices in all major clinics and rehab hospitals in the developed world, and even in patients homes.

Some 700,000 US citizens suffer strokes every year. Of these, some 500,000 require therapy for problems with language, memory or movement. It is the last aspect that is the focus of M.I.T. robots.

When Mary ORegan of Massachusetts first tried the Myomo device,
'"/>




Page: 1 2 3 4

Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. New FDA Approved Drug To Treat Migraine
3. New FDA Approved Drug NATRECOR For Heart Failure Patients
4. FDA Approves Contraceptive Ring
5. FDA Approves New HIV Drug, Viread
6. FDA Approves Birth Control Skin Patch
7. FDA Approves New Arthritis Drug, Bextra
8. FDA Approves Elidel Cream for Eczema
9. FDA Approves New Anti-Clotting Drug
10. FDA Approves New surgery Treatment for Farsightedness
11. FDA Approves Anti-Cancer Cell Drug - Zevalin
Post Your Comments:
(Date:11/21/2008)...ate University College of Medicine research team l...w layer of regulation in the cell division cycle, ... way cancer begins. , Wang, an assistant profess...ne, said the findings will lead to an improved abi...gn of new drugs that kill cancer cells by inhibiti...
(Date:11/21/2008)...FirstCall/ -- Heska Corporation,(Nasdaq: HSKA )...ociety of,Security Analysts, 12th Annual Biotech ...08 at 1177 Avenue of the Americas, 2nd Floor in Ne...n at 9:35 a.m. Eastern Time (7:35 a.m.,Mountain T...r two weeks,following the presentation through a ...
(Date:11/21/2008)... future antibiotic resistance from widespread use ...- People with moderate to severe chronic obstructi...the frequency of exacerbations through a regular, .... , The study, published in the first issue fo... and Critical Care Medicine , found that twice-dai...
(Date:11/21/2008)...re/ -- The University of Texas M. D. Anderson Ca...e effort to eradicate breast cancer in Panama thro...d Research of the Americas today at an event with ...nd Vivian Fernandez de Torrijos, the First Lady of...initiative are the U.S. Department of State and Su...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3
... phone users were closely monitored by scientists ...gen to study //the harmful effects of cell phone u... cell phones for over a decade. Few were using cel...been proven by scientists in previous studies that...
... face danger at the wards due to insufficient doct...e consultants are too busy to take time off their/...l College of Obstetricians and Gynecologists condu... 10% of the emergencies during childbirth, the mid...
...xperts are hoping to exploit the passion for crick...urage people from the community not to delay calli... Research shows that South Asians in Britain have ...m heart disease than the general population. But S...
...say Reaves of the University of Minnesota School o...upplements on a daily basis tend to have a healthi... the December Journal of American Dietetic Associa...an 2500 US high school seniors. They were analyzed...
Other Medicine News:Health News:British Heart Experts Use Cricket To Target South Asians 2
(Date:11/19/2008)... THOUSAND OAKS, Calif., Nov. 19 /PRNewswire-First...The Takeda Oncology Company, a subsidiary of,Take...ay announced that,enrollment in the Phase 3 MONET...tion with paclitaxel and carboplatin for the first...ancer (NSCLC) has been temporarily suspended,foll...
(Date:11/19/2008)... -Triggers $5 Million Payment from Roche- , ,... -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY )...nt goal for its Phase 2 trial of R3487/MEM 3454, i...nitive impairment associated with schizophrenia (C...the Phase 2 trial, triggering a $5.0 million payme...
(Date:11/18/2008)... American Lung Association,s 2008 Faces of Influe...milies immunized against influenza; Mother and Gol... , WASHINGTON, Nov. 18 While 7... influenza a severe and potentially life-threateni...t is likely their families will get vaccinated thi...
(Date:11/12/2008)... NEW YORK, Nov. 12 ...ne edition of Cell will help answer the,question, ... pressing questions in the medical research into,P...lls in the brain to die,in the first place. Answer...cause there are two nearly identical types of brai...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Echocardiography Lab at Presbyterian Hospital of Dallas Achieves Prestigious Reaccreditation 21094 1Echocardiography Lab at Presbyterian Hospital of Dallas Achieves Prestigious Reaccreditation 21094 2Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance 5813 1Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance 5813 2Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance 5813 3Heart Patients More Likely to Adopt Healthy Habits in 3 Year Program Led by Cardiac Rehabilitation Experts Mayo Clinic Research Shows 2327 1Heart Patients More Likely to Adopt Healthy Habits in 3 Year Program Led by Cardiac Rehabilitation Experts Mayo Clinic Research Shows 2327 2Heart Patients More Likely to Adopt Healthy Habits in 3 Year Program Led by Cardiac Rehabilitation Experts Mayo Clinic Research Shows 2327 3Heart Patients More Likely to Adopt Healthy Habits in 3 Year Program Led by Cardiac Rehabilitation Experts Mayo Clinic Research Shows 2327 4Cooling May Not Help Injured Brains in Children 21089 1Cooling May Not Help Injured Brains in Children 21089 2Cooling May Not Help Injured Brains in Children 21089 3
Triad Plus Sterile Isopropyl Alcohol 70% USP Swabsticks are primarily used as a topical antiseptic prior to administering injections. They are gamma sterilized to meet AAMI/ANSI/ISO 11137 standar
BETADINE® Solution Swabsticks are indicated whenever a topical microbicide is applied most conveniently with a swabstick.
The design of the new ChloraPrep swabstick applicator provides significant improvement in performance over traditional swabsticks.
...Swabsticks are packaged in easy open, single-use f...turated with precisely the correct amount of solut...ng the safest possible product for the patient. It...spital and office procedures, providing protection...
Medicine Products: